The Veterinary Drug Approval Process and FDA Regulatory Oversight

  • 1899.00 Dollar US$
  • Published date: December 18, 2020
    • san Jose, california, United States

The U.S. Food and Drug Administration’s Center for Veterinary Medicine (CVM) is responsible for the approval of veterinary drug products intended for family pets, food-producing animals, and other animal species. This seminar will cover the process for obtaining federal government approval for marketing new animal drug products that are under the jurisdiction of the FDA, and also briefly covers animal products that are regulated by other federal agencies. For example, animal vaccines, animal disease diagnostic devices and some animal biologics are regulated by the U.S. Department of Agriculture, and some flea and tick control products are regulated by the Environmental Protection Agency.

This two-day interactive seminar will provide attendees with an understanding of FDA’s veterinary drug approval process. The group size is small, generally between 8 and 20 people, with plenty of opportunities to ask questions and discuss issues or challenges that the attendees have experienced.

Result 0 votes
Ashutos Swain
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)

    Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (CMOs)

    Drug Development san Jose (california) December 18, 2020 1899.00 Dollar US$

    The globalization of the pharmaceutical supply chain has resulted in the increased use of Contract Manufacturing Organizations (CMOs). The use of CMOs provides many benefits; however, it also presents unique compliance risks, particularly since opera...

  • Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation)

    Process Validation Guidance Requirements (FDA and EU Annex 15: Qualifications and Validation)

    Drug Development san Jose (california) November 28, 2020 1699.00 Dollar US$

    The Process Validation Guidelines (January 2011) and the EU Annex 15: Qualification and Validation (October 2015) outline the general principles and approaches the two regulatory bodies consider appropriate elements of process validation for the manu...

  • ANDA Submission and GDUFA Guidance

    ANDA Submission and GDUFA Guidance

    Drug Development Palo Alto (California) September 22, 2020 329.00 Dollar US$

    In order to properly, effectively, and efficiently bring generic drugs and medicinal products to market, it is crucial to anyone interacting with the submittal process to understand how the process is structured and functions